Abstract |
On August 13-14, 1987 the Halogenated Organics Subcommittee of the Science Advisory Board's Environmental Health Committee met in Washington, D.C. to review two documents prepared by EPA's Office of Research and Development that assess health effects associated with dichloromethane (methylene chloride). The documents included: a June 1987 Draft Technical Analysis of New Methods and Data Regarding Dichloromethane: Pharmacokinetics, Mechanism of Action and Epidemiology, a July 1987 Draft Addendum to the Health Assessment Document for Dichloromethane: Pharmacokinetics, Mechanism of Action and Epidemiology. The Subcommittees concluded that the Addendum was one of the best documents it has received in terms of its clarity, coverage of the data and analysis of scientific issues. The document clearly demonstrates the potential utility of pharmacokinetics data in risk assessment. |